Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Professor Selena Bartlett from QUT's Institute of Health and Biomedical Innovation (IHBI) and an ambassador for Women in Technology (WiT) said trials would soon begin to test whether varenicline, commonly known as Champix, can effectively treat problem drinkers.
"It's well known that many people with serious alcohol dependency also smoke so we've been trying to better understand the mechanisms behind that," Professor Bartlett said.
"We know that the reward from both drinking and smoking is tied up in the neuronal nicotinic receptors in the brain - Champix binds to these receptors and helps reduce the need to drink at problem levels."
Professor Bartlett, who last night presented the findings at the 2013 Scientific Conference of the Australasian Professional Society on Alcohol and other Drugs (APSAD), said initial findings showed the 'quit smoking' drug effectively turned long-term drinkers into 'social' drinkers.
The drug also normalised dopamine deficiencies, which affect reward-motivated behaviour, in long-term heavy drinkers.
"We tend to look more toward abstinence when treating problem drinkers, which is very difficult in the long-run," she said.
"We've seen that using Champix suppresses the need for the behaviour that we consider 'problem drinking' by reducing the amount of alcohol needed.
"By being able to curb problem drinking we will effectively be able to reduce harm in the general population."
Clinical trials will begin next year in New South Wales in collaboration with a team lead by Associate Professor Nicholas Lintzeris from Sydney University.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Alcohol / Addiction / Illegal Drugs category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Queensland University of Technology. "Quit-smoking drug to make problem drinking 'social'." Medical News Today. MediLexicon, Intl., 28 Nov. 2013. Web.
10 Mar. 2014. <http://www.medicalnewstoday.com/releases/269453>
Queensland University of Technology. (2013, November 28). "Quit-smoking drug to make problem drinking 'social'." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269453.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.